MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-20 |
Device Problems
Migration or Expulsion of Device (1395); Material Split, Cut or Torn (4008)
|
Patient Problems
Abdominal Pain (1685); Numbness (2415)
|
Event Date 11/29/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: product id: 8598a, serial#: (b)(4), implanted: (b)(6) 2020, product type: catheter.Other relevant device(s) are: product id: 8598a, serial/lot #: (b)(4), ubd: 10-sep-2022, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from multiple sources (healthcare provider, clinical study) regarding a patient who was receiving fentanyl (2000 mcg at 300.39113 mcg/day) and bupivacaine (20 mg at 3.00391 mg/day) via an implantable pump for unknown indications for use.It was reported that on (b)(6) 2020 the patient reported severe numbness in legs after using personal therapy manager (ptm) and fell. it was noted the patient's legs were numb for approximately 2 hours. it was noted the ptm would help with leg pain, but not abdominal pain. a catheter dye study was performed on (b)(6) 2020 and revealed the catheter was dislodged and in the subcutaneous tissue. no action was taken at this time, but a catheter revision was scheduled for (b)(6) 2020. the outcome of the event was noted as ongoing. the device diagnosis was catheter dislodgement and the clinical diagnosis was numbness in legs. the etiology of the event indicated the relationship of the event to the device or therapy was related and indicated the relationship of the event to the implant procedure was unlikely related. the event date was (b)(6) 2020. no further complications were reported/anticipated.
|
|
Manufacturer Narrative
|
Continuation of d10: product id 8598a serial# (b)(6) (b)(6) 2020.Product type catheter medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from a health care provider via a device manufacturer representative on (b)(6) 220.It was reported that during the catheter replacement surgery, it was discovered that the catheter anchor had been cut by the suture which resulted in the catheter dislodgement, migration, and loss of therapy.The catheter segment was replaced and the issue was considered resolved.
|
|
Manufacturer Narrative
|
H3: the catheter was returned, and analysis found the anchor had a broken suture ring - event related.H6: all previously reported result, method, and result codes no longer apply to this event.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|